• Policy
• MFDS reviews Pfizer COVID-19 vaccine used without dilution
• by Lee, Tak-Sun Dec 2, 2021 05:54am

• Policy
• Did Mooncare truly reinforce coverage for rare diseases?
• by Eo, Yun-Ho Dec 1, 2021 05:57am

• Company
• Prevenar 13 sales take ‘roller-coaster’ ride with COVID-19
• by Chon, Seung-Hyun Dec 1, 2021 05:56am

• Company
• SGLT-2i Jardiance adds chronic heart failure indication
• by Eo, Yun-Ho Nov 30, 2021 05:52am

• Policy
• 30 new drug items reimbursed or extended coverage this year
• by Kim, Jung-Ju Nov 30, 2021 05:52am

• Policy
• Review period & material improved for COVID-19 Txs, etc.
• by Lee, Jeong-Hwan Nov 29, 2021 05:58am

• Opinion
• [Reporter’s View] On the best way to issue impurity recalls
• by Lee, Tak-Sun Nov 29, 2021 05:58am

• Company
• Ildong started developing a treatment for COVID-19
• by Nho, Byung Chul Nov 29, 2021 05:58am

• Policy
• A new pre-approval system for Ultomiris was established
• by Lee, Hye-Kyung Nov 29, 2021 05:58am

• Company
• Samsung BIOEPIS set a new sales record in a year
• by Chon, Seung-Hyun Nov 29, 2021 05:58am